Baby Safety / Compounds / Amphetamine

Is Amphetamine safe for babies and kids?

Elevated risk for kids

Infants are more vulnerable to Amphetamine than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What is amphetamine?

The IUPAC name is 1-phenylpropan-2-amine.

Also known as: 1-phenylpropan-2-amine, Amfetamine, dl-Amphetamine, 1-Phenyl-2-aminopropane.

IUPAC name
1-phenylpropan-2-amine
CAS number
300-62-9
Molecular formula
C9H13N
Molecular weight
135.21 g/mol
SMILES
CC(CC1=CC=CC=C1)N
PubChem CID
3007

Risk for babies

Elevated risk

Infants are more vulnerable to Amphetamine than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Risk for pregnant and nursing people

Context-dependent

Pregnancy alters the metabolism and distribution of Amphetamine, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

3 regulatory and scientific bodies have classified Amphetamine. The classifications differ — that's the data.

AgencyYearClassificationNotes
EPA CTX / GenetoxGenotoxicity: positive (Ames: equivocal, 2 positive / 1 negative reports)
EPA CTX / GenetoxGenotoxicity: positive (Ames: equivocal, 2 positive / 1 negative reports)
EPA CTX / Skin-EyeSkin Irritation: SkinIrr2 (score: high)

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter amphetamine

  • Industrial FacilitiesManufacturing plants, Chemical storage areas, Waste treatment sites
  • Occupational EnvironmentsFactories, Warehouses, Transportation vehicles

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Amphetamine:

  • Therapeutic alternatives (consult prescriber)
    Trade-offs: Drug-specific. Cannot substitute without medical guidance.
    Relative cost: 1.2-2×

Frequently asked questions

Is amphetamine safe for kids?

Infants are more vulnerable to Amphetamine than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What products contain amphetamine?

Amphetamine appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).

What should I do if my child is exposed to amphetamine?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Why do regulators disagree about amphetamine?

Amphetamine has been classified by 3 agencies including EPA CTX / Genetox, EPA CTX / Genetox, EPA CTX / Skin-Eye, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.

See Amphetamine in the baby app

Look up products containing amphetamine, compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (3)

  1. US DEA: Amphetamine — Schedule II Classification, ADHD/Narcolepsy FDA Approvals, Mixed Amphetamine Salts (Adderall), Lisdexamfetamine (Vyvanse) Prodrug, Diversion and Misuse, and College Campus Nonmedical Use Prevalence (2022) (2022) — regulatory
  2. US FDA: Mixed Amphetamine Salts (Adderall/Adderall XR) — Prescribing Information, Pediatric Growth Effects, Cardiovascular Screening, Overdose Toxidrome Management, and ADHD Efficacy Data (2022) (2022) — regulatory
  3. ASPCA Animal Poison Control Center: Amphetamines (ADHD Medications) in Dogs — Adderall/Vyvanse Ingestion, Hyperthermia, Tremors, Benzodiazepine Management, and APCC Case Series (2022) (2022) — regulatory

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →